01-01-2017
Experience in the Use of the β-Interferon-1a Biosimilars CinnoVex and Genfaxon-44 at the Moscow City Multiple Sclerosis Center
Published in: Neuroscience and Behavioral Physiology | Issue 1/2017
Login to get access01-01-2017
Published in: Neuroscience and Behavioral Physiology | Issue 1/2017
Login to get access